Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents
- 1 July 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 24 (2-3), 245-257
- https://doi.org/10.1016/0166-3542(94)90071-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The problem of antiviral therapy for chronic hepadnavirus infectionsJournal of Hepatology, 1993
- Antiviral therapy of hepatitis C — present and futureJournal of Hepatology, 1993
- Antiviral therapy of chronic hepatitis B: past, present, and futureJournal of Hepatology, 1993
- The hepatitis B virus and the host responseJournal of Hepatology, 1990
- Absence of Effect of Zidovudine on Replication of Hepatitis B Virus in Patients with Chronic HIV and HBV InfectionNew England Journal of Medicine, 1989
- A pilot study of BW A515U (6-deoxyacyclovir) in chronic hepatitis B virus infectionJournal of Hepatology, 1986
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitisDigestive Diseases and Sciences, 1983
- Lymphocyte cytotoxicity in human liver disease using rat hepatocyte monolayer culturesClinical Immunology and Immunopathology, 1980
- Immunotherapy of patients with chronic virus B hepatitisClinical Immunology and Immunopathology, 1980